Continuing its research on developing natural remedies from marine organisms against lifestyle diseases, the Central Marine Fisheries Research Institute (CMFRI) on Tuesday claimed it had developed a nutraceutical product from select seaweeds to treat non-alcoholic fatty liver disease (NAFLD).
Named Cadalmin TM LivCure extract, the product is a blend of 100% natural bioactive ingredients extracted from seaweed with an eco-friendly green technology to improve liver health, according to a press release from the CMFRI.
This is the ninth such product from marine organisms developed by the CMFRI which had previously brought out nutraceuticals to combat a series of lifestyle diseases, such as Type-2 diabetes, arthritis, cholesterol, hypertension, hypothyroidism, and osteoporosis, and to improve immunity. Out of these nutraceuticals, eight products are from seaweed and one from green mussel, the release said.
